A proposal for clinical trials of COVID-19 treatment using homo-harringtonine
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
National science review - 8(2021), 1 vom: 21. Jan., Seite nwaa257 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wen, Hai-Jun [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 02.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/nsr/nwaa257 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332162451 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332162451 | ||
| 003 | DE-627 | ||
| 005 | 20240402235029.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/nsr/nwaa257 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1360.xml |
| 035 | |a (DE-627)NLM332162451 | ||
| 035 | |a (NLM)34676091 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wen, Hai-Jun |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A proposal for clinical trials of COVID-19 treatment using homo-harringtonine |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 02.04.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Liu, Feng-Liang |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Ming-Xing |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Rong-Hua |e verfasserin |4 aut | |
| 700 | 1 | |a He, Wen-Bin |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Fang-Liang |e verfasserin |4 aut | |
| 700 | 1 | |a Cai, Qi-Chun |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Hua-Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Zi-Feng |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Xi |e verfasserin |4 aut | |
| 700 | 1 | |a Shang, You |e verfasserin |4 aut | |
| 700 | 1 | |a Lyu, Xue-Mei |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Ding-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Xiao, Fei |e verfasserin |4 aut | |
| 700 | 1 | |a Shan, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a He, Jian-Xing |e verfasserin |4 aut | |
| 700 | 1 | |a Zheng, Yong-Tang |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Chung-I |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t National science review |d 2014 |g 8(2021), 1 vom: 21. Jan., Seite nwaa257 |w (DE-627)NLM243751931 |x 2053-714X |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2021 |g number:1 |g day:21 |g month:01 |g pages:nwaa257 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/nsr/nwaa257 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2021 |e 1 |b 21 |c 01 |h nwaa257 | ||